Vγ9/Vδ2 T lymphocytes in Italian patients with Behçet's disease - evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor β1expression in active disease

Arthritis Research and Therapy

Volumn 5, Issue 5, 2003, Pages

  Triolo, Giovanni ^a   Accardo Palumbo, Antonina ^b   Dieli, Francesco ^b   Ciccia, Francesco ^a   Ferrante, Angelo ^a   Giardina, Ennio ^a   Di Sano, Caterina ^b   Licata, Giuseppe ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Beh et's disease; Interleukin 12; Tumour necrosis factor; T lymphocyte

Indexed keywords

ANTIGEN; INTERLEUKIN 12 RECEPTOR BETA1; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR 2; XYLOSE; IL12RB1 PROTEIN, HUMAN; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; BEHCET DISEASE; CELL EXPANSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; ITALIAN (CITIZEN); LYMPHOCYTE PROLIFERATION; MALE; PATHOGENESIS; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; T CELL CULTURE; T LYMPHOCYTE ACTIVATION; BIOSYNTHESIS; BLOOD; CELL CULTURE; CELL DIVISION; GENETICS; ITALY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE;

ADULT; BEHCET SYNDROME; CELL DIVISION; CELLS, CULTURED; FEMALE; HUMANS; ITALY; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES;

EID: 2342511636     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar785     Document Type: Article

References (37)

1. Mizuki N, Inoko H, Ando H, Nakamura S, Kashiwase K, Akara T, Fujino Y, Masuda K, Takiguchi M, Ohno S: Behçet's disease associated with one of theHLA-B51 subantigens, HLAB*5101. Am J Ophthalmol 1993, 116:406-409.
2. Takeno M, Kaiyone A, Yamashita N, Takiguchi M, Mizushima Y, Kaneoka H, Sakane T: Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 1995, 38:426-433.
3. Sakane T, Kotani H, Takada S, Tsunematsu T: Functional aberration of T cell subsets in patients with Behçet's disease.Arthritis Rheum 1982, 25:1343-1351.
4. Emmi L, Salvati G, Brugnolo F, Marchione T: Immunopathological aspects of Behçet's disease. Clin Exp Rheumatol 1995, 13:687-691.
5. Triolo G, Accardo-Palumbo A, Triolo G, Carbone MC, Ferrante A, Giardina E: Enhancement of endothelial cell E-selectin expression by sera from patients with active Behçet's disease: moderate correlation with anti-endothelial cell antibodies and myeloperoxidase levels.Clin Immunol 1999, 91:330-337.
6. Accardo-Palumbo A, Triolo G, Carbone MC, Ferrante A, Ciccia F, Giardina E, Triolo G: Polymorphonuclear leukocyte myeloperoxidase levels in patients with Behçet's disease. Clin Exp Rheumatol 2000, 18:495-498.
7. Gul A, Esin S, Dilsen N, Konice E, Wigzell H, Biberfeld P: Immunohistology of skin pathergy reaction in Behçet's disease. Br J Dermatol 1995, 132:901-907.
8. +lymphocyte involvement in ocular Behçet's disease.Autoimmunity 1992, 12:201-206.
9. Fortune F, Walker J, Lehner T: The expression of γ/δT cell receptor and the prevalence of primed, activated and IgAbound T cells in Behçet's syndrome. Clin Exp Immunol 1990, 82:326-332.
10. Komano H, Fujiura Y, Kawaguchi M, Matsumoto S, Hashimoto Y, Obana S, Mombaerts P, Tonegawa S, Yamamoto H, Itohara S, et al.: Homeostatic regulation of intestinal epithelia by intra epithelial γ/δT cells.Proc Natl Acad Sci USA1995,92:6147-6151.
11. Chien Y-H, Jores R, Crowley MP: Recognition by γ/delta;T cells. Annu Rev Immunol 1996, 14:511-532.
12. Tanaka Y, Morita CT, Tanaka Y, Nieves E, Brenner MB, Bloom BR: Natural and synthetic non peptide antigens recognized by human γ/δT cells. Nature 1995, 375:155-158.
13. Dieli F, Asherson GL, Romano GC, Sireci G, Gervasi F, Salerno A: IL-4 is essential for systemic transfer of delayed hypersensitivity by T cell lines. J Immunol 1994, 152:2698-2704.
14. Ferrick DA, Schrenzel MD, Mulvania T, Hsieh B, Ferlin WG, Lepper H: Differential production of interferon αand interleukin 4 in response to Th1 and Th2-stimulating pathogens by γδT cells in vivo. Nature 1995, 373:255-257.
15. Inaba G, Sakane T: Role of γδT lymphocytes in the development of Behçet's disease. Clin Exp Immunol 1997, 107:241-247.
16. Hamzaoui K, Hamzaoui A, Hentati F, Kahan A, Ayed K, Chabbou A, Ben Hamida M, Hamza M: Phenotype and functional profile of T cell expressing gamma delta receptor from patients with active Behçet's disease. Rheumatol 1994, 21:2301-2306.
17. Hasan A, Fortune F, Wilson A, Warr K, Shinnick T, Mizushima Y, van der Zee R, Stanford MR, Sanderson J, Lehner T: Role of gamma delta T cells in pathogenesis and diagnosis of Behçet's disease. Lancet 1996, 347:789-794.
18. Salerno A, Dieli F: Role of gamma-delta T lymphocyte in immune response in humans and mice. Crit Rev Immunol 1998, 18:327-357.
19. Burk MR, Mori L, De Libero G: Human Vγ9-Vδ2 cells are stimulated in a cros-reactive fashion by a variety of phosphorylated metabolites. Eur J Immunol 1995, 25:2052-2058.
20. Bukowski JF, Morita CT, Tanaka Y, Bloom BR, Brenner MB, Band H: Vγ9-Vδ2 TCR-dependent recognition of non-peptide antigens and Daudi cells analysed by TCR gene transfer. J Immunol 1995, 154:998-1006.
21. Bukowski JF, Morita CT, Brenner MB: Recognition and destruction of virus-infected cells by human γ/δCTL. J Immunol 1994, 153:5133-5140.
22. Ueta C, Kawasumi H, Fujiwara H: Interleukin-12 activates human γ/δT cells: synergistic effect of tumor necrosis factor-α. Eur J Immunol 1996, 26:3066-3073.
23. Frassanito MA, Dammacco R, Cafforio P, Dammacco F: Th1 polarization of the immune response in Behçet's disease. Arthritis Rheum 1999, 42:1967-1974.
24. International Study Group for Behçet's Disease: Criteria for diagnosis of Behçet's disease.Lancet 1990, 103:177-184.
25. Behçet's Disease Research Committee of Japan. Criteria for activity of Behçet's disease. In Annual Report of Behçet's Disease: Research Committee of Japan. Edited by Sakane T. Japan: Ministry of health and welfare of Japan; 1994.
26. Dieli F, Sireci G, Di Sano C, Romano A, Titone L, Di Carlo P, Ivanyi J, Fournie JJ, Salerno A: Ligand-specific αβand γδT cell responses in childhood tuberculosis. J Infect Dis 2000, 181:294-301.
27. Direskeneli H, Eksioglu-Demiralp E, Kibaroglu A, Yavuz S, Ergun T, Akoglu T: Oligoclonal T cell expansions in patients with Behçet's disease.Clin Exp Immunol 1999, 117:166-170.
28. Janeway CA Jr Jones B, Hayday A: Specificity and function of T cells bearing γδreceptors.Immunol Today 1988, 9:73-76.
29. Keystone E, Rittershaus C, Wood N, Snow K, Flatow J, Purvis J: Elevation of a γδT cell subset in peripheral blood and synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 1991, 84:78-82.
30. Roura-Mir IC, Alcalde L, Vargas F, Tolosa E, Obiols G, Foz M, Jaraquemada D, Pujol-Borrell R: γδT lymphocytes in endocrine autoimmunity: evidence for expansion in Graves disease but not in type 1 diabetes.Clin Exp Immunol 1993, 92:288-295.
31. Martins EBG, Graham AK, Chapman RW, Fleming KA: Elevation in γδT lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases. Hepatology 1996, 23:988-993.
32. Shimonkevitz R, Colburn C, Burham JA, Murray RS, Kotzin BL: Clonal expansion of activated γδT cells in recent-onset multiple sclerosis.Proc Natl Acad Sci USA1993, 90:923-927.
33. Freysdottir J, Lau S, Fortune F: γδT cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol 1999, 118:451-457.
34. Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaroglu IC, Dundar S, Kirazli S: Cytokines in Behçet's disease. J Rheumatol 1996, 23: 321-322.
35. Mege JL, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, Ocal L, Inanc M, Capo C: Overproduction of monocyte derived tumor necrosis factor a, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease: a comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993, 20:1544-1549.
36. Kosar A, Haznedaroglu S, Karaaslan Y, Buyukasik Y, Haznedaroglu IC, Ozath D, Sayinalp N, Ozcebe O, Kirazli S, Dundar S: Effects of interferon-alpha2a treatment on serum levels of tumor necrosis factor-alpha, tumor necrosis alpha 2 receptor, interleukin-2, interleukin-2 receptor, and e-selectin in Behçet's disease. Rheumatol Intern 1999, 19:11-14.
37. Tartaglia LA, Pennica D, Goeddel DV: Ligand passing: the 75-kDA tumor necrosis factor (TNF) receptor recruits TNF for signalling by the 55-kDA TNF receptor. J Biol Chem 1993, 268: 18542-18548.